Cited by 20CRISPR and Genetic EngineeringImmunodeficiency and Autoimmune DisordersImmune Response and Inflammation

Dissecting mammalian immunity through mutation

Open access
Siggs, Owen M·2014·Immunology & Cell Biology

Abstract

Although mutation and natural selection have given rise to our immune system, a well‐placed mutation can also cripple it, and within an expanding population we are recognizing more and more cases of single‐gene mutations that compromise immunity. These mutations are an ideal tool for understanding human immunology, and there are more ways than ever to measure their physiological effects. There are also more ways to create mutations in the laboratory, and to use these resources to systematically define the function of every gene in our genome. This review focuses on the discovery and creation of mutations in the context of mammalian immunity, with an emphasis on the use of genome‐wide chemical and CRISPR/Cas9 mutagenesis to reveal gene function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/icb.2014.8

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adoptive T-cell therapy, in which genetically engineered T cells are re-infused into patients, has shown survival-improving effects in clinical trials.

    “Adoptive T-cell therapy, for example, in which genetically engineered T cells were re-infused back into patients, has shown survival improving effects in clinical trials.69”

    From CRISPR-Cas9: a new and promising player in gene therapy (2015) · cites this paper as [69]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Siggs, O. M.
Affiliations
Wellcome Sanger Institute (GB)
Corresponding author
Siggs, Owen M
Venue
Immunology & Cell Biology
Publisher
Wiley
Published
2014-02-11
Volume
92
Issue
5
Pages
392-399
ISSN
  • 0004-945X (ISSN-L)
  • 0818-9641
  • 1440-1711
OpenAlex
W1971974049
Cited by
20
References
100
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 4 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1
FWCI
0.16
Type
journal article
Language
en
Open access
Locations
  • Immunology and Cell Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Wellcome Trust (100083/Z/12/Z)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
single-gene mutations, immunodeficiency, gene function, CRISPR/Cas9 mutagenesis, human immunology
MeSH terms
Animals, Genotype, Humans, Immunity, Mammals, Mutation, Phenotype, Genetic Association Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review